Slovak Diabetes Society recommendations for diabetes education
Authors:
Marek Macko Vedúci Autorského Kolektívu; Andrea Bukovská; Peter Galajda; Marián Mokáň; Zbynek Schroner; Za Výbor Slovenskej Diabetologickej Spoločnosti
Published in:
Diab Obez 2024; 24(1): 33-35
Category:
Reviews
Overview
MUDr. Marek Macko | marekmackox@gmail.com
Doručené do redakcie | Received 6. 4. 2024
Sources
Bukovská A, Galajda P, Mokáň M. Edukácia a sociálne poradenstvo v diabetológii. P+M: Turany 2014. ISBN 978–80–89694–04–4.
IDF. International Curriculum for Diabetes Health Professional Education. International Diabetes Federation: Brussels 2008. 2nd ed. ISBN 2–930229–62–4.
Davis J, Fischl AH, Beck J et al. National Standards for Diabetes Self-Management Education. Diabetes care 2022; 45(2): 484–494. Dostupné z DOI. <https://doi.org/10.2337/dc21–2396>.
Jirkovská A, Jirkovská J, Čechová K et al. Skupinová edukace diabetiků. Geum: Praha 2017. ISBN 978–80–87969–33–5.
Mokáň M, Martinka E, Galajda P et al. Diabetes mellitus a vybrané metabolické ochorenia. P+M: Turany 2008. ISBN 978–80–969713–9-8.
Powers MA, Bardsley J, Cypress M et al. Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. J Acad Nutr Diet 2015; 115(8): 1323–1334. Dostupné z DOI: <https://doi: 10.1016/j.jand.2015.05.012>.
CHRVALA AC, Sherr D, Lipman RD et al. Diabetes self-management education for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns 2016; 99(6): 926–943. Dostupné z DOI: <https://doi: 10.1016/j.pec.2015.11.003>.
Labels
Diabetology ObesitologyArticle was published in
Diabetes and obesity
2024 Issue 1
Most read in this issue
- Early use of SGLT2-inhibitors i in the treatment of type 2 diabetes mellitus
- Current position of GLP-1 receptor agonists in type 2 diabetes mellitus treatment
- Type 2 diabetes mellitus and obesity – dangerous companions
- Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus